
CSAN Earnings
Cosan SA
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Cosan SA(CSAN) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Cosan SA earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: BRL
Actual
Estimate
Surprise Analysis
FY2025Q1 | 2025-05-15 | After Hours | - | - | - | 40.65B | 9.66B | -76.23 | -2.02 | - |
- | 2025-02-26 | After Hours | - | - | - | - | - | - | +4.51 | +1.43 |
- | 2024-08-26 | After Hours | - | - | - | - | - | - | -0.69 | -8.93 |
- | 2024-05-28 | - | - | -0.08 | - | - | - | - | -0.74 | -3.52 |
FY2023Q2 | 2023-08-14 | - | -0.14 | 0.07 | +150.00 | 41.48B | 34.50B | -16.82 | -2.18 | -6.79 |
- | 2022-02-18 | - | 0.03 | 0.15 | +400.00 | - | - | - | -4.49 | -7.16 |
CSAN Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Cosan SA reported performance for FY2025Q1, announced on 2025-05-15. The company achieved an EPS of , compared to analyst estimates of by % . Revenue for the quarter reached 9.66B compared to expectations of 40.65B by -76.23% .
The stock price reacted with a -2.02% one-day change and a 0.00% five-day change following the earnings release. These movements reflect market reaction in Cosan SA growth trajectory and strategic initiatives.
CSAN Earnings Forecast
Looking ahead, Cosan SA(CSAN) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q2 project quarter revenue of 36.81B and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -5.23%, while EPS estimates have been Revise Upward by 97.3%. For the upcoming Q2 2025, revenue estimates have been adjusted Revise Downward by -3.58% . These revisions correlate with a -24.13% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Cosan SA long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between CSAN's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward

-5.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+97.3%
In Past 3 Month
Revenue Estimates for Q2 2025
Revise Downward

-3.58%
In Past 3 Month
Stock Price
Go Down

-24.13%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:157.54B
--
EPS Estimate-Annual FY 2025:2.60
—
Stock Price4.12
CSAN Revenue and EPS Performance: A Historical Perspective
Cosan SA revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q1 (2025-05-15,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 9.66B (Actual) vs. 40.65B (Estimate) (-76.23%)
Price Reaction: -2.02%(1-Day), 0.00%(5-Day)
(2025-02-26,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 4.51%(1-Day), 1.43%(5-Day)
(2024-08-26,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -0.69%(1-Day), -8.93%(5-Day)
Earnings Reaction
The chart below shows how CSAN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CSAN sees a +3.46% change in stock price 10 days leading up to the earnings, and a -2.72% change 10 days following the report. On the earnings day itself, the stock moves by -1.78%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2025, the stock changed -2.02% on the day following the earnings release and then changed by 7.17% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Cosan SA (CSAN) Q1 2025 Earnings Call Summary
Neutral
2025-05-20
The earnings call presents mixed signals. While there are positive factors like improved debt management and dividends, challenges like operational setbacks, safety risks, and competitive pressures are evident. The Q&A reveals management's cautious stance on divestments and strategic priorities, indicating uncertainties. Despite some positive steps, the lack of clear guidance and operational difficulties suggest a cautious market reaction. The company's market cap suggests moderate sensitivity to these factors, leading to a neutral stock price prediction.
Cosan SA (CSAN) Q4 2024 Earnings Call Summary
Negative
2025-02-27
The earnings call highlighted several negative factors, including increased debt, operational challenges, and currency depreciation impacts. Despite stable EBITDA and increased dividends, the negative earnings and unclear future strategies from management in the Q&A section suggest uncertainty. The lack of clear guidance and ongoing challenges, like safety issues and market performance, overshadow positive aspects like dividends and strategic divestments, leading to a negative sentiment.
Cosan S.A. (CSAN) Q3 2024 Earnings Call Summary
Positive
2024-11-14
The earnings call summary shows strong financial performance with a 15% revenue increase and improved operational metrics. The company anticipates a 10% revenue growth and stable margins, indicating confidence in future performance. Despite some risks, management's proactive approach to supply chain challenges and new product launches suggests positive future outcomes. The Q&A session reflects optimism and strategic focus, although lacking specific revenue targets. Considering the market cap, the overall sentiment is positive, likely resulting in a 2% to 8% stock price increase over the next two weeks.
Cosan S.A. (CSAN) Q2 2024 Earnings Call Summary
Neutral
2024-08-15
The earnings call summary presents a mixed outlook. While EBITDA increased and financial health improved, the net result was negative, and operational delays pose risks. The Q&A reveals concerns about liability management and market challenges, but management is focused on deleveraging and value creation. Despite some positive aspects, such as dividend payments and improved debt metrics, uncertainties around interest rates, market demand, and regulatory challenges suggest a neutral sentiment. The market cap indicates moderate sensitivity to these factors, supporting a neutral stock price movement prediction.
People Also Watch

RXRX
Recursion Pharmaceuticals Inc
5.290
USD
-1.31%

KLIC
Kulicke and Soffa Industries Inc
35.060
USD
-1.02%

MRCY
Mercury Systems Inc
53.580
USD
+1.42%

ENR
Energizer Holdings Inc
27.900
USD
-3.06%

SGRY
Surgery Partners Inc
22.740
USD
-3.81%

BANC
Banc of California Inc
14.480
USD
-0.41%

ODD
Oddity Tech Ltd
58.500
USD
+0.48%

AIN
Albany International Corp
61.320
USD
+0.62%

IREN
IREN Ltd
17.970
USD
-2.60%

AMRX
Amneal Pharmaceuticals Inc
8.840
USD
+3.51%
FAQ

What were the key highlights of CSAN’s latest earnings report for FY2025Q1?
CSAN reported its FY2025Q1 earnings on 2025-05-15, showcasing a revenue of 9.66B against an estimate of 40.65B, resulting in a -76.23% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a -2.02% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

How did CSAN’s stock price react after the FY2025Q1 earnings release?

What are the revenue and EPS estimates for CSAN for 2025/Q2?

How does CSAN’s stock price correlate with earnings forecast revisions?

What should investors expect from CSAN’s next earnings report?
